×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Clinical: UB-311 Alzheimer's Vaccination Trial
clinical
1,914 words
KG: UB-311 Alzheimer's Vaccination Trial
2026-03-28
kind:clinical-trial
section:clinical-trials
state:published
Contents
UB-311 Alzheimer's Vaccination Trial
Knowledge Graph
Related Hypotheses (16)
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
APOE Isoform Conversion Therapy
Score: 0.44
Phase-Separated Organelle Targeting
Score: 0.52
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
Orexin-Microglia Modulation Therapy
Score: 0.49
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.48
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41
Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.39
Show 11 more
Related Analyses (8)
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Show 3 more
Related Experiments (2)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40
See Also (15)
vitamin-d-therapy-neurodegeneration
therapeutic · Pages share 4 hypotheses
TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses
Trace Amine-Associated Receptor (TAAR) Modulator Therap
therapeutic · Pages share 4 hypotheses
SYK Kinase Inhibitor Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses
STING Inhibitor Therapy in Neurodegeneration
therapeutic · Pages share 4 hypotheses
Specialized Pro-Resolving Mediator (SPM) Therapy for Ne
therapeutic · Pages share 4 hypotheses
Specialized Pro-Resolving Mediator (SPM) Therapies for
therapeutic · Pages share 4 hypotheses
Somatostatin Receptor Modulator Therapy in Neurodegener
therapeutic · Pages share 4 hypotheses
Section 152: Advanced Robotics and Assistive Devices in
therapeutic · Pages share 4 hypotheses
Section 147: Telehealth and Remote Monitoring in CBS/PS
therapeutic · Pages share 4 hypotheses
S100 Protein (S100A8/A9/A12) Modulator Therapy for Neur
therapeutic · Pages share 4 hypotheses
RNA Targeting Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses
Progranulin Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses
nt-3-therapy-neurodegeneration
therapeutic · Pages share 4 hypotheses
Neurotensin Receptor Modulator Therapy for Neurodegener
therapeutic · Pages share 4 hypotheses
Show 10 more
Knowledge Graph (1 edges)
UB-311 Alzheimer's Vaccination Trial
references
APOE